Answers are grounded in this paper and cite their sources.
Objectives: Excisional goniotomy using the Kahook Dual Blade (KDB) is one of several minimally invasive glaucoma surgery options developed as a safer alternative to traditional filtering procedures such as trabeculectomy and tube shunt implantation, which are highly effective but carry well-described safety risks. This study assessed the efficacy and safety of KDB goniotomy in patients with mild-to-moderate open-angle glaucoma. Materials and Methods: This prospective interventional study included 30 eyes of 30 patients with mild-to-moderate open-angle glaucoma undergoing KDB goniotomy, standalone or combined with phacoemulsification. Baseline demographic and clinical data, including glaucoma type and severity, pre- operative intraocular pressure (IOP) and number of anti-glaucoma medications (AGM), were recorded. Follow-up visits were conducted at post-operative day 1, 1 week, 1, 3 and 6 months, evaluating changes in IOP, medication usage and adverse events. Surgical success was defined as ≥20% IOP reduction from baseline or ≥1 AGM reduction at 6 months. Results: Mean IOP decreased from 16.20 ± 4.99 mmHg preoperatively to 12.83 ± 3.27 mmHg at 6 months (mean reduction 16.6%; paired t -test p < 0.001). Mean AGM count reduced from 2.10 ± 1.27 to 0.33 ± 0.71 ( p < 0.001). The composite success criterion was met in 29/30 eyes (96.7%); 15/30 (50.0%) met the IOP criterion alone and 28/30 (93.3%) met the AGM criterion alone. Complications occurred in 11 eyes (36.7%), most commonly transient IOP spike (23.3%); no sight-threatening complications occurred. Six-month IOP did not differ significantly by baseline severity ( p = 0.892) or surgery type (standalone KDB vs. KDB combined with phacoemulsification; p = 0.175) but differed significantly across diagnosis subgroups ( p = 0.017). Conclusion: KDB goniotomy, standalone or combined with phacoemulsification, produced significant and sustained IOP reduction and decreased glaucoma medication burden over 6 months, with a favourable safety profile and no sight-threatening complications.
No takes yet. Share an insight, caveat, or question.
Sindusha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: